In support of our conclusion, we also injected UMRC2 cells engineered with PIK3R3 overexpression subcutaneously into the flanks of NSG mice and observed decreased tumor progression and tumor size (Supplemental Figure 10, E–G). The gene discussed is PIK3R3; the disease is neoplasm.